We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack

By MedImaging International staff writers
Posted on 05 Dec 2025
Image: CXCR4-targeted PET imaging reveals hidden inflammatory activity (Diekmann, J. et al., J Nucl Med (2025). DOI: 10.2967/jnumed.125.270807)
Image: CXCR4-targeted PET imaging reveals hidden inflammatory activity (Diekmann, J. et al., J Nucl Med (2025). DOI: 10.2967/jnumed.125.270807)

Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure. Inflammation plays a central role in determining how the heart heals, but conventional imaging captures only irreversible injury and not the dynamic immune response. Now, a new PET imaging approach allows physicians to quickly identify patients who are at risk for poor functional recovery after a heart attack.

In a study led by Hannover Medical School (Lower Saxony, Germany), a research team focused on a PET imaging strategy that visualizes CXCR4, a key inflammatory protein expressed after cardiac injury. Investigators conducted multimodal assessments that included CXCR4-targeted PET/CT, myocardial perfusion imaging, and cardiac MRI in 49 patients within the first week of a heart attack. Forty participants returned for follow-up MRI roughly eight months later to evaluate structural and functional outcomes.

The imaging analysis revealed that CXCR4 activity extended beyond the central infarct and into the surrounding border zone, aligning closely with later declines in left ventricular function. These findings, published in The Journal of Nuclear Medicine, demonstrate that early CXCR4 upregulation correlates with adverse remodeling, offering a mechanistic link between inflammation and long-term injury. This supports CXCR4-PET as a predictive marker in the critical post-infarction window.

The work highlights how targeting inflammation could refine patient stratification. Excessive inflammatory signaling may identify individuals who could benefit from emerging anti-inflammatory or reparative therapies to prevent progression toward heart failure. Researchers plan to explore how imaging-guided interventions might optimize treatment timing and personalize care based on each patient’s inflammatory profile.

"By including CXCR4-targeted PET, we can identify patients who exhibit excessive or prolonged inflammation which may predispose them to adverse remodeling and heart failure. Such information could, in the future, support risk stratification and guide emerging anti-inflammatory or reparative therapies in a precision medicine framework," said Johanna Diekmann, MD, lead investigator of the study. "What's more, this approach may ultimately facilitate image-guided therapeutic strategies, allowing nuclear medicine to play an active role in monitoring and optimizing interventions that modulate inflammation, repair, and regeneration after cardiac injury."

Related Links:
Hannover Medical School

Breast Localization System
MAMMOREP LOOP
Medical Radiographic X-Ray Machine
TR30N HF
Pocket Fetal Doppler
CONTEC10C/CL
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Channels

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.